Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Real-life benefits of statins for cardiovascular prevention in elderly subjects: a population-based cohort study.

Bezin J, Moore N, Mansiaux Y, Steg PG, Pariente A.

Am J Med. 2019 Jan 17. pii: S0002-9343(19)30062-2. doi: 10.1016/j.amjmed.2018.12.032. [Epub ahead of print]

PMID:
30660573
2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

3.

Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.

Zhan S, Tang M, Liu F, Xia P, Shu M, Wu X.

Cochrane Database Syst Rev. 2018 Nov 19;11:CD012502. doi: 10.1002/14651858.CD012502.pub2. Review.

PMID:
30480766
4.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
5.

Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.

Shalev V, Goldshtein I, Porath A, Weitzman D, Shemer J, Chodick G.

Am J Cardiol. 2012 Dec 15;110(12):1779-86. doi: 10.1016/j.amjcard.2012.08.013. Epub 2012 Sep 25.

PMID:
23021514
6.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

7.

New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women's Health.

Jones M, Tett S, Peeters GM, Mishra GD, Dobson A.

Drugs Aging. 2017 Mar;34(3):203-209. doi: 10.1007/s40266-017-0435-0.

PMID:
28138911
8.
9.

Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.

Ramos R, Comas-Cufí M, Martí-Lluch R, Balló E, Ponjoan A, Alves-Cabratosa L, Blanch J, Marrugat J, Elosua R, Grau M, Elosua-Bayes M, García-Ortiz L, Garcia-Gil M.

BMJ. 2018 Sep 5;362:k3359. doi: 10.1136/bmj.k3359.

10.

Effect of Statin Therapy on Mortality in Older Adults Hospitalized with Coronary Artery Disease: A Propensity-Adjusted Analysis.

Rothschild DP, Novak E, Rich MW.

J Am Geriatr Soc. 2016 Jul;64(7):1475-9. doi: 10.1111/jgs.14207. Epub 2016 Jun 13.

PMID:
27295083
11.

Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan.

Lin ZF, Wang CY, Shen LJ, Hsiao FY, Lin Wu FL.

Can J Diabetes. 2016 Jun;40(3):264-9. doi: 10.1016/j.jcjd.2015.12.006. Epub 2016 Mar 15.

PMID:
26992286
12.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
13.

Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.

Rannanheimo PK, Tiittanen P, Hartikainen J, Helin-Salmivaara A, Huupponen R, Vahtera J, Korhonen MJ.

Value Health. 2015 Sep;18(6):896-905. doi: 10.1016/j.jval.2015.06.002. Epub 2015 Aug 5.

14.

Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.

Savarese G, Gotto AM Jr, Paolillo S, D'Amore C, Losco T, Musella F, Scala O, Marciano C, Ruggiero D, Marsico F, De Luca G, Trimarco B, Perrone-Filardi P.

J Am Coll Cardiol. 2013 Dec 3;62(22):2090-9. doi: 10.1016/j.jacc.2013.07.069. Epub 2013 Aug 28. Erratum in: J Am Coll Cardiol. 2014 Mar 25;63(11):1122.

15.
16.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
17.

Continuation of statin treatment and all-cause mortality: a population-based cohort study.

Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD.

Arch Intern Med. 2009 Feb 9;169(3):260-8. doi: 10.1001/archinternmed.2008.552.

PMID:
19204217
18.

Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.

Ramos R, García-Gil M, Comas-Cufí M, Quesada M, Marrugat J, Elosua R, Sala J, Grau M, Martí R, Ponjoan A, Alves-Cabratosa L, Blanch J, Bolíbar B.

J Am Coll Cardiol. 2016 Feb 16;67(6):630-640. doi: 10.1016/j.jacc.2015.11.052.

19.

Statin-associated incident diabetes: a literature review.

Park ZH, Juska A, Dyakov D, Patel RV.

Consult Pharm. 2014;29(5):317-34. doi: 10.4140/TCP.n.2014.317. Review.

PMID:
24849689
20.

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.

Supplemental Content

Support Center